Influence
June 12, 2020

Regenstrief research scientist leading effort to improve COVID-19 preparedness in Indiana nursing homes

Regenstrief Institute research scientist Kathleen Unroe, M.D., MHA, and her company Probari, Inc. are working with the Indiana State Department of Health to protect the residents and staff of Indiana nursing homes during the COVID-19 pandemic. State officials enlisted Probari to assist in providing education and training at more than 500 facilities around the state.

Supported by the State Department of Health, Probari nurses are instructing facility staff on COVID-19 guidelines and training them in infectious disease control and prevention. This undertaking is especially important because the close contact required in nursing homes can spread the virus quickly, and the people who live there are at high risk for complications from COVID-19.

Regenstrief made a financial and an operational investment in Probari and holds a stake in the company. The company works to improve the overall healthcare experience of residents at nursing homes and long-term facilities using the OPTIMISTIC care model. The model was created and proven through a Centers for Medicare and Medicaid Innovation project.

Related News

photo background showing data, etc.

Regenstrief Institute will host collaborative conference to improve public health data

Due to previous year’s high demand, virtual attendance option added  The Public Health Informatics Program in the Center for

Study reports chlamydia and gonorrhea more likely to be treated per CDC guidelines in males, younger patients and individuals identifying as Black or multiracial

Study reports chlamydia and gonorrhea more likely to be treated per CDC guidelines in males, younger patients and individuals identifying as Black or multiracial

But significant numbers of those living with these diseases don’t receive this treatment INDIANAPOLIS – Chlamydia and gonorrhea are

Aaron Carroll, M.D.

Call for Papers on Artificial Intelligence Applied to Pediatric Care

Published in JAMA Pediatrics. Here is a link to the article. Regenstrief Institute author: Aaron E. Carroll, M.D., M.S.